Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Drug Development Acquisition Focuses on Treatment for Movement Disorders

The purchase of a biomedical company that develops drugs for treatment of hyperkinetic movement disorders by one of the world's largest producers of generic drugs is expected to strengthen the generics manufacturer's position in the market for central nervous system condition treatments.  More...
12 Apr 2015

Biotech Collaboration to Promote Animal-Based Cancer Research

Two American biotechnology companies have signed a collaboration agreement that is intended to promote animal-based cancer research and drug development.  More...
05 Apr 2015

“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery

Two mass spectrometry technologies, MALDI and DESI, are increasing in applications as their effectiveness is established, according to Kalorama Information in its report “Proteomics Markets for Research and IVD Applications - Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies.”  More...
29 Mar 2015
Image: Under a new partnership for liquid handling measurement automation, Artel will provide STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates, under the name Artel “SDS” - Sample Detection System (Photo courtesy of Artel).

Artel Expands Portfolio with STRATEC Partnership for Automation Technology

Artel, a leader in laboratory liquid handling measurement systems, and STRATEC Biomedical, a leader in automated systems for clinical diagnostics and biotechnology, have entered into a strategic partnership for STRATEC’s innovative “Tholos” technology, which measures liquid and solid contents of 96- and 384-well microplates.   More...
16 Feb 2015

Roche Acquires Signature Diagnostics to Advance Translational Research

Roche will advance translational research for next generation sequencing diagnostics by leveraging the unique expertise of Signature Diagnostics in biobanks and development of novel NGS diagnostic assays.  More...
15 Feb 2015

Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

Dedicated Computing, a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market.    More...
25 Jan 2015

Biotech Acquisition Designed to Accelerate the Development and Marketing of Immunosequencing Applications

Adaptive Biotechnologies, a developer of next-generation sequencing (NGS) to profile T-cell and B-cell receptors, has acquired of Sequenta, which is expected to expedite and expand the use of innovative immunosequencing technology for researchers and clinicians to diagnose, treat, and monitor patients with cancer, autoimmune disorders, and infectious diseases.  More...
19 Jan 2015
powered by:

Product Showcase

BioResearch Industry News channel updates the reader on mergers and takeovers, on cooperative agreements and on trends in the biotech industry worldwide.
Copyright © 2000-2017 Globetech Media. All rights reserved.